PATENT CLAIM ANALYSIS

Application Number: 16153449
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["424", "139100"]

Abstract:
The present invention provides an antibody that specifically binds to human CD69, has an activity to suppress allergic inflammation, and has cross-reactivity with mouse CD69. In addition, the present invention provides an antibody having high binding affinity for human CD69 and an activity to suppress allergic inflammations. The antibody of the present invention can be a human antibody.

Claim (Index 26):
The method according to  claim 20 ,\n wherein the light chain variable region comprises the amino acid sequence of SEQ ID NO: 23, 27 or 28, and wherein the heavy chain variable region comprises the amino acid sequence of SEQ ID NO: 24.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.77778
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16063515', '14440391', '14796956', '15188860', '14807522']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7274963780366918
- 35 USC 102 Novelty (BERT): 0.5237472287154485
- Combined Prediction Score: 0.7071214631045675
- Mean Citation Score: 298.833738
- Max Citation Score: 313.0887
- Similarity Product: 238.97304729359155

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test